Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Parkinson's Disease

Free Subscription 22.12.2025 1 BMC Neurol 1 Brain Res 1 J Clin Psychopharmacol 1 JAMA 6 Mov Disord 1 Neurobiol Dis 1 Neuroscience 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Neurol

1. LI J, Zhou R, Deng J, Zhou H, et al
   Sleep disorders in Parkinson's disease: evaluating pharmacological treatments through systematic review and meta-analysis.
   BMC Neurol. 2025;25:504.
   PubMed         Abstract available
   
   

   
   Brain Res

2. HUA YH, Huang XY, Ma JJ, Wu J, et al
   Ezetimibe mitigates microglial activation in Parkinson's disease via TLR4/JNK pathway inhibition: evidence from network pharmacology and experimental validation.
   Brain Res. 2025 Dec 17:150116. doi: 10.1016/j.brainres.2025.150116.
   PubMed         Abstract available
   
   

   
   J Clin Psychopharmacol

3. LE V, Surineni K, Preskorn S
   Use of Oral Aripiprazole to Rapidly Reverse Paliperidone LAI-Induced Parkinsonism Without Causing New Adverse Effects.
   J Clin Psychopharmacol. 2025 Dec 19. doi: 10.1097/JCP.0000000000002103.
   PubMed        
   
   

   
   JAMA

4. PANT S
   Untreated Sleep Apnea May Elevate Parkinson Disease Risk.
   JAMA. 2025 Dec 19. doi: 10.1001/jama.2025.20029.
   PubMed        
   
   

   
   Mov Disord

5. BEZDICEK O, Biundo R, Skorvanek M, Weintraub D, et al
   Author Response to Comment on "Neuropsychological Tests of Memory, Visuospatial, and Language Function in Parkinson's Disease: Review, Critique, and Recommendations".
   Mov Disord. 2025 Dec 16. doi: 10.1002/mds.70149.
   PubMed        
   
   
6. WOLLER JP, Gharabaghi A
   Comment on "Neuropsychological Tests of Memory, Visuospatial, and Language Function in Parkinson's Disease: Review, Critique, and Recommendations".
   Mov Disord. 2025 Dec 16. doi: 10.1002/mds.70148.
   PubMed        
   
   
7. PROIETTI F, Ottaviani MM, Burchi E, Vivacqua G, et al
   Vagus Nerve Stimulation in Movement Disorders, from Principles to a Systematic Review of Evidence.
   Mov Disord. 2025;40:2559-2577.
   PubMed         Abstract available
   
   
8. HARING V, Selzam V, Martin-Rodriguez JF, Schwingenschuh P, et al
   Phenotypical Differentiation of Tremor Using Time Series Feature Extraction and Machine Learning.
   Mov Disord. 2025;40:2628-2640.
   PubMed         Abstract available
   
   
9. CHURCHILL L, Ignatavicius A, Konuri A, Anderson J, et al
   Functional Magnetic Resonance Imaging (fMRI) Signatures of Progression and Phenoconversion in Prodromal Synucleinopathies.
   Mov Disord. 2025;40:2664-2677.
   PubMed         Abstract available
   
   
10. WANG L, Tanglay O, Su F, Li H, et al
    Distinct AQP4 Alterations in Movement Disorders with Primary Synucleinopathy.
    Mov Disord. 2025;40:2804-2810.
    PubMed         Abstract available
    
    

    
    Neurobiol Dis

11. BERNARD K, Corenblum MJ, Tonino P, Madhavan L, et al
    Bioenergetic and protein processing imbalances in iPSC-dopamine neurons from individuals with idiopathic Parkinson's disease.
    Neurobiol Dis. 2025 Dec 12:107222. doi: 10.1016/j.nbd.2025.107222.
    PubMed         Abstract available
    
    

    
    Neuroscience

12. SANCHEZ-MONCADA I, Neri-Nani G, Jefte AE, Merchant H, et al
    Preferred tempo influence on learning transfer from perceptual to stepping timing in Parkinson's disease.
    Neuroscience. 2025 Dec 17:S0306-4522(25)01206.
    PubMed         Abstract available
    
    

    
    PLoS One

13. TAN QY, Ibrahim K, Roberts HC, Amar K, et al
    A mixed-methods study to explore the modifiable aspects of treatment burden in Parkinson's disease and develop recommendations for improvement.
    PLoS One. 2025;20:e0338620.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.